Examination and characterisation of the effect of amitriptyline therapy for chronic neuropathic pain on neuropeptide and proteomic constituents of human cerebrospinal fluid

INTRODUCTION: Amitriptyline is prescribed to reduce the intensity of chronic neuropathic pain. There is a paucity of validated in vivo evidence in humans regarding amitriptyline’s mechanism of action. We examined the effect of amitriptyline therapy on cerebrospinal fluid (CSF) neuropeptides and prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Royds, Jonathan, Cassidy, Hilary, Conroy, Melissa J., Dunne, Margaret R., Lysaght, Joanne, McCrory, Connail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474617/
https://www.ncbi.nlm.nih.gov/pubmed/34589721
http://dx.doi.org/10.1016/j.bbih.2020.100184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474617/
https://www.ncbi.nlm.nih.gov/pubmed/34589721
http://dx.doi.org/10.1016/j.bbih.2020.100184

Ejemplares similares